Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 160 | 200 |
| Receivables | 10 | 8 |
| Other current assets | 30 | 52 |
| TOTAL | $200 | $260 |
| Non-Current Assets | ||
| TOTAL | $N/A | $N/A |
| Total Assets | $220 | $280 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 1,030 | 1,810 |
| Other current liabilities | 30 | 0 |
| TOTAL | $1,060 | $1,810 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 380 | 0 |
| TOTAL | $380 | $N/A |
| Total Liabilities | $1,450 | $1,810 |
| Shareholders' Equity | ||
| Common Shares | 36,370 | 35,170 |
| Retained earnings | -44,480 | -42,890 |
| Other shareholders' equity | 1,700 | 1,740 |
| TOTAL | $-1,230 | $-1,520 |
| Total Liabilities And Equity | $220 | $290 |